ONC Q3 2023 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q3 2023 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$781M+101.6% YoY

Gross Profit

$685M87.7% margin

Operating Income

-$134M-17.1% margin

Net Income

$215M27.6% margin

EPS (Diluted)

$1.95

QoQ Revenue Growth

+31.3%

Cash Flow

Operating Cash Flow

-$78M

Free Cash Flow

-$260M

Stock-Based Comp.

$96M

Balance Sheet

Total Assets

$5.5B

Total Liabilities

$1.8B

Stockholders' Equity

$3.8B

Cash & Equivalents

$3.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$781M	$388M	+101.6%
Gross Profit	$685M	$311M	+120.2%
Operating Income	-$134M	-$438M	+69.4%
Net Income	$215M	-$558M	+138.6%